Rhythm Pharmaceuticals In... (RYTM)
NASDAQ: RYTM
· Real-Time Price · USD
97.69
1.21 (1.25%)
At close: Aug 15, 2025, 3:59 PM
97.50
-0.19%
After-hours: Aug 15, 2025, 06:27 PM EDT
Rhythm Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 48.5M | 32.7M | 41.83M | 33.25M | 29.08M | 25.97M | 24.23M | 22.5M | 19.22M | 11.47M | 8.79M | 4.28M | 9.07M | 1.5M | 1.82M | 1.03M | 274K | 35K |
Cost of Revenue | 5.54M | 3.65M | 3.79M | 3.83M | 3.12M | 3M | 3.23M | 2.41M | 2.24M | 1.42M | 1.03M | 497K | 378K | 230K | 236K | 222K | 137K | 4K |
Gross Profit | 42.96M | 29.06M | 38.04M | 29.42M | 25.95M | 22.97M | 21M | 20.09M | 16.98M | 10.05M | 7.76M | 3.79M | 8.69M | 1.27M | 1.58M | 806K | 137K | 31K |
Operating Income | -45.3M | -47M | -41.26M | -43.88M | -40.48M | -139.89M | -41.27M | -43.95M | -46.6M | -52.53M | -42.1M | -39.27M | -45.1M | -52.69M | -50.99M | -44.24M | -40.43M | -34.4M |
Interest Income | 3.24M | 3.64M | 3.52M | 4.05M | 4.1M | 3.05M | 3.82M | 3.47M | 3.22M | 3.44M | 3.04M | 920K | 274K | 160K | 134K | 138K | 21K | 154K |
Pretax Income | -46.3M | -49.42M | -43.38M | -43.98M | -31.78M | -141.07M | -41.44M | -43.8M | -46.7M | -52.18M | -42.49M | -40.86M | -45M | -52.76M | -50.86M | -44.1M | -40.41M | 65.76M |
Net Income | -46.63M | -49.5M | -43.29M | -43.64M | -32.26M | -141.37M | -41.63M | -44.16M | -46.7M | -51.83M | -42.49M | -42.45M | -45M | -52.84M | -42.87M | -35.11M | -35.39M | 43.75M |
Selling & General & Admin | 45.95M | 39.09M | 38.13M | 35.38M | 36.41M | 34.38M | 32.37M | 30.48M | 30.05M | 24.63M | 26.32M | 21.94M | 22.33M | 21.45M | 21M | 17.51M | 15.46M | 14.52M |
Research & Development | 42.31M | 36.97M | 41.17M | 37.93M | 30.02M | 128.47M | 29.89M | 33.57M | 33.54M | 37.95M | 23.55M | 21.12M | 31.46M | 32.51M | 31.57M | 27.54M | 25.1M | 19.91M |
Other Expenses | n/a | n/a | n/a | n/a | 302K | 524K | 559K | -159K | -17K | -27K | n/a | -370K | -133K | -233K | n/a | n/a | n/a | n/a |
Operating Expenses | 88.25M | 76.06M | 79.3M | 73.31M | 66.43M | 162.86M | 62.27M | 64.05M | 63.59M | 62.58M | 49.87M | 43.05M | 53.78M | 53.96M | 52.57M | 45.05M | 40.57M | 34.43M |
Interest Expense | 5.82M | 5.41M | 5.45M | 5.24M | 4.6M | 4.75M | 4.55M | 3.15M | 3.3M | 3.06M | 3.01M | 2.14M | 46K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 93.8M | 79.71M | 83.08M | 77.14M | 69.56M | 165.85M | 65.5M | 66.46M | 65.83M | 64M | 50.89M | 43.55M | 54.16M | 54.19M | 52.81M | 45.27M | 40.71M | 34.43M |
Income Tax Expense | 337K | 80K | -90K | -344K | 479K | 300K | 196K | 368K | 82K | -352K | n/a | 1.59M | -87K | 73K | -7.99M | -8.99M | -5.02M | 22.01M |
Shares Outstanding (Basic) | 63.68M | 63.06M | 61.6M | 61.22M | 61.01M | 60.14M | 59.21M | 57.87M | 56.87M | 56.71M | 56.3M | 51.4M | 50.4M | 50.25M | 50.27M | 50.25M | 50.21M | 47.64M |
Shares Outstanding (Diluted) | 63.68M | 63.06M | 61.6M | 61.22M | 61.01M | 60.14M | 59.21M | 57.87M | 56.87M | 56.71M | 56.3M | 51.4M | 50.4M | 50.33M | 50.27M | 50.25M | 50.21M | 48.5M |
EPS (Basic) | -0.75 | -0.81 | -0.72 | -0.71 | -0.53 | -2.35 | -0.7 | -0.76 | -0.82 | -0.91 | -0.75 | -0.83 | -0.89 | -1.05 | -0.85 | -0.7 | -0.7 | 0.92 |
EPS (Diluted) | -0.75 | -0.81 | -0.72 | -0.71 | -0.53 | -2.35 | -0.7 | -0.76 | -0.82 | -0.91 | -0.75 | -0.83 | -0.89 | -1.05 | -0.85 | -0.7 | -0.7 | 0.90 |
EBITDA | -40.1M | -47M | -37.55M | -38.36M | -26.79M | -135.91M | -36.99M | -40.1M | -42.86M | -48.57M | -39.04M | -38.34M | -44.63M | -52.41M | -50.66M | -43.79M | -40.12M | -34.2M |
EBIT | -40.48M | -44.01M | -37.94M | -38.74M | -27.18M | -136.32M | -36.89M | -40.65M | -43.4M | -49.12M | -39.48M | -38.72M | -44.95M | -52.69M | -50.99M | -44.1M | -40.43M | -34.4M |
Depreciation & Amortization | 379K | 383K | 383K | 385K | 391K | 405K | 417K | 544K | 540K | 551K | 442K | 374K | 373K | 285K | 325K | 315K | 317K | 201K |